Functional brain networks in migraine and meditation

April 9, 2023

I’ve previously written about the benefits of meditation and how it has helped alleviate my migraines. I recommend it to all of my patients.

A recent study published in the Journal of Headache and Pain by Chinese researchers examined changes in resting-state functional networks in the brain and their correlation with clinical traits in migraine patients.

The study used EEG and fMRI to compare 24 migraine patients with 26 healthy controls. The subjects were evaluated for migraine-related disability using the MIDAS score, cognitive functioning, anxiety, and depression.

The researchers found that the decrease of functional connectivity within the default mode network (DMN) and between DMN and executive control network (ECN) in migraine patients was negatively correlated with MIDAS score.

They also found differences in various other functional networks, but the difference in DMN connectivity caught my attention because of its association with meditation. Studies using fMRI have shown that engaging in meditation leads to a decrease in DMN activity and an increase in the activation of brain regions responsible for cognitive and emotional regulation.

Altered connectivity in the DMN has been associated with a range of neuropsychiatric conditions such as depression, anxiety, post-traumatic stress disorder, attention deficit hyperactive disorder, and obsessive-compulsive disorder. Psychedelics are also thought to produce their effect, at least in part, by acting on the DMN.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe